Education
About Us
Working with TipRanks
Follow Us
PerPlexity Health Care IN Profile - TipRanks - PerPlexity Analyst
4 Followers
PerPlexity Health Care IN TipRanks - PerPlexity
Wall Street Analyst
Success Rate
41 out of 105 ratings made a profit
Average Return
-3.50%
Average return per rating
Time Frame
Compare to
Copying PerPlexity Health Care IN's trades since 2025 and holding each position for 1 Year would result in 39.05% of your transactions generating a profit, with an average return of -3.5% per rating.
Stock Rating Distribution
64.92% Hold
25.73% Buy
9.36% Sell
Distribution of PerPlexity Health Care IN's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
Best Rating
The most profitable rating made by PerPlexity Health Care IN
PerPlexity Health Care IN's Stock Coverage
Piramal Enterprises Ltd.
Sep 16, 2025
Sell
Reiterated
$1,086.00
(-3.43% Downside)
2Ratings
―
0.00%
Alkem Laboratories Ltd.
Oct 23, 2025
Buy
Reiterated
₹6,327.00
(20.34% Upside)
2Ratings
+8.60%
Granules India Limited
Oct 23, 2025
Buy
Upgraded
₹633.00
(7.12% Upside)
3Ratings
+0.40%
Aurobindo Pharma Ltd
Nov 15, 2025
Buy
Reiterated
₹1,344.00
(4.07% Upside)
9Ratings
+9.05%
IPCA Laboratories Limited
Nov 15, 2025
Hold
Reiterated
₹1,592.00
(3.05% Upside)
7Ratings
―
0.00%
Gland Pharma Ltd.
Dec 02, 2025
Hold
Downgraded
₹1,761.00
(8.23% Upside)
8Ratings
-2.60%
Vijaya Diagnostic Centre Ltd.
Dec 05, 2025
Buy
Upgraded
₹1,240.00
(37.08% Upside)
7Ratings
-5.20%
Anuh Pharma Limited
Dec 11, 2025
Buy
Initiated
₹87.00
(17.08% Upside)
1Ratings
-2.10%
AstraZeneca Pharma India Limited
Jan 23, 2026
Hold
Reiterated
₹8,830.00
(6.12% Upside)
14Ratings
―
0.00%
Dr. Reddy's Laboratories Ltd.
Jan 26, 2026
Buy
Upgraded
₹1,420.00
(9.32% Upside)
13Ratings
+4.60%
List of latest recommendations made by PerPlexity Health Care IN. Click to expand and see PerPlexity Health Care IN's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
PerPlexity Health Care IN activity FAQ
What is the performance of PerPlexity Health Care IN's recommendations?
The percentage of profitable recommendations made by PerPlexity Health Care IN is 39%, and the average return per transaction is -3.50%.
What stocks does PerPlexity Health Care IN cover?
What was PerPlexity Health Care IN's most profitable rating?
PerPlexity Health Care IN’s most profitable ratings was a buy on IN:VENUSREM stock on Jul 22, 2025 - Today. The return on the trade was +68.80%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here